Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
Journal of Neurology, Neurosurgery, and Psychiatry|November 25, 2022
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in ItalyAndrea Mastrangelo, Angela Mammana, Simone Baiardi, et al.International Journal of Molecular Sciences|February 26, 2022
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt-Jakob DiseaseSamir Abu-Rumeileh, Peggy Barschke, Patrick Oeckl, et al.The American Journal of Case Reports|June 22, 2018
Cognitive Rehabilitation and Transcranial Direct Current Stimulation in a Patient with Posterior Cortical Atrophy: An fMRI StudyLaura Ludovica Gramegna, Stefania Evangelisti, Claudia Testa, et al.Journal of Affective Disorders|September 2, 2022
Influence of chronotype on the incidence and severity of perinatal depression in the "Life-ON" studyCorrado Garbazza, Sandra Hackethal, Enrica Migliore, et al.Alzheimer'S Research & Therapy|January 2, 2020
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementiaSamir Abu-Rumeileh, Petra Steinacker, Barbara Polischi, et al.NPJ Parkinson'S Disease|August 15, 2024
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorderAmaia Muñoz-Lopetegi, Simone Baiardi, Mircea Balasa, et al.NPJ Parkinson'S Disease|October 12, 2021
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromesCorinne Quadalti, Giovanna Calandra-Buonaura, Simone Baiardi, et al.Acta Neuropathologica|February 17, 2017
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levelsFrancesca Lattanzio, Samir Abu-Rumeileh, Alessia Franceschini, et al.NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.Brain : a Journal of Neurology|December 17, 2024
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrumAndrea Mastrangelo, Angela Mammana, Sara Hall, et al.Pageof 11